MyAverix Finance
F · Healthcare
GENOVIS AB SE-40 (5GV)
Biotechnology
GENOVIS AB SE-40 (5GV) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 5GV
GENOVIS AB SE-40 (5GV) — FAQ
What is 5GV's P/E ratio?
The price-to-earnings (P/E) ratio for GENOVIS AB SE-40 (5GV) is 25.00 (data as of 2026-05-23).
Does GENOVIS AB SE-40 pay a dividend?
Dividend yield is not available in the current snapshot for GENOVIS AB SE-40 (5GV). Check the MyAverix Finance app for the latest dividend data.
What sector is GENOVIS AB SE-40 in?
GENOVIS AB SE-40 (5GV) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 5GV listed on?
5GV is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.